Clinical Development - read more

Phase I, IIa, IIb/IIIa, IIIb -
A dedicated and proven team will provide:

  • Protocol development
  • Clinical Trial Feasibility
  • Indication experience
  • Coverage
  • Central Study management
  • European central submission services
  • Risk Management Plans
  • On-site Monitoring and centralized Monitoring techniques as well as Risk-based Monitoring approaches
  • Reporting
  • Quick study set-up
  • Innovative patient recruitment support solutions

 

Find out, how AMS  Clinical Research services fit to your needs:

Talk or write to us:

ClinicalResearch bottom

• 2022 – AMS are CTR- and MDR ready • 2022 – New unique AMS-ePRO® features launched • 2022 – Real-World Evidence focus in AMS Late-Stage Research • 2022 – AMS expanded its global reach • 2021 – DIGA dossier submission pioneer •

News